Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) How to limit bias in quasiexperimental studies
Journal Information
Vol. 38. Issue 1.
Pages 45-46 (January 2020)
Vol. 38. Issue 1.
Pages 45-46 (January 2020)
Letter to the Editor
Full text access
How to limit bias in quasiexperimental studies
Cómo limitar los sesgos en estudios cuasiexperimentales
Visits
952
María Dolores del Toro Lópeza,b,
Corresponding author
mdeltoro@us.es

Corresponding author.
, Jesús Rodríguez-Bañoa,b
a Unidad Clínica de Enfermedades Infecciosas, Microbiología Clínica y Medicina Preventiva, Hospital Universitario Virgen Macarena, Sevilla, Spain
b Departamento de Medicina, Universidad de Sevilla, Instituto de Biomedicina de Sevilla, Sevilla, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor,

In the abridged original entitled “Dual prophylaxis with teicoplanin added to cefazolin in the prevention of prosthetic joint infection”,1 the authors try to demonstrate in a retrospective work the effectiveness of this regimen in the reduction of prosthetic joint infections caused by gram-positive cocci in primary and elective surgery of hip and knee arthroplasty. We would like to thank the authors for their contribution, and, while it is true that prophylaxis with beta-lactams plus teicoplanin could be considered in some situations, there is no quality evidence in the literature that supports the use of dual prophylaxis.2–8 The authors recognise the limitations of their work as it is not a randomised study. However, in order to evaluate the effectiveness of an intervention in a quasi-experimental study, it is desirable, in addition to the usual bivariate analyses, to take into account other factors that have not been considered and which are frequent with before–after studies, such as mean regression, maturation effect and confounding variables. Regression to the mean is a phenomenon whereby when results are at their extreme points, they are most likely about to start the way back to a midpoint and, therefore, the change could have occurred without the intervention. The maturation effect is another phenomenon whereby the results obtained are due to changes that patients experience over time or seasonal cycles. To reduce the probability of these two phenomena occurring, it is necessary to observe the trend of the outcome variable before the intervention, and to make a longer observation after the intervention or the change of regimen to verify that there is neither a tendency to the mean nor a maturation effect. Confounding factors are frequent in all before-after studies, especially if the work is retrospective. In the work in question, a logistic regression would have made it possible to control various confounding factors, such as the Charlson index and transfusions, which were significantly more frequent in the control group, or colonisation by methicillin-resistant Staphylococcus aureus which, although without significant differences, occurred in twice as many patients in the control group. In this type of work, it is also desirable to reflect the adherence to preventive measures that have been proven to be effective in preventing surgical infection such as the decolonisation of S. aureus carriers, the adequate preparation of patients (hygiene, shaving, disinfection of the skin), the control of perioperative blood glucose, adherence to antibiotic prophylaxis used or changes in surgical practice (drainage, etc.). The “standard” logistic regression in this type of study does not estimate the trend or the slope of the changes after an intervention, so the results obtained may be biased and the changes in time (trend) may not be detected. Segmented regression techniques make it possible to estimate the association between an intervention and the outcome variable controlling for confounding factors, and estimate the changes in the mean at different levels (interception) and trends (slopes). The limitations of these statistics are that they require data from multiple time intervals before and after the intervention (≥10 observations/model and parameter to be studied) to avoid over-adjustments, but it is possible to have ≥24 observations (e.g. 12 months before and 12 months after the intervention). Potential stationary changes can even be detected.

Quasi-experimental studies are widely used to observe the impact of certain interventions in the prevention and treatment of osteoarticular infection due to the difficulty of conducting randomised clinical trials, so it is important that they are carried out with an appropriate methodology. Otherwise, biased results may lead to inappropriate clinical practice. We encourage all researchers to take these concepts into account when designing and analysing the results of a quasi-experimental work. We believe that the results of this study may encourage conducting a randomised trial, but should not lead to a change in clinical practice.

References
[1]
J.M. Barbero-Allende, M. García-Sánchez, E. Montero-Ruiz, A. Vallés-Purroy, M.Á. Plasencia-Arriba, J. Sanz-Moreno.
Dual prophylaxis with teicoplanin and cefazolin in the prevention of prosthetic joint infection [Article in English, Spanish].
Enferm Infecc Microbiol Clin, 37 (2019), pp. 588-591
[2]
A. Sewick, A. Makani, C. Wu, J. O’Donnell, K.D. Baldwin, G.C. Lee.
Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty?.
Clin Orthop Relat Res, 470 (2012), pp. 2702-2707
[3]
B. Ponce, B.T. Raines, R.D. Reed, C. Vick, J. Richman, M. Hawn.
Surgical site infection after arthroplasty: comparative effectiveness of prophylactic antibiotics: do surgical care improvement project guidelines need to be updated?.
J Bone Joint Surg Am, 96 (2014), pp. 970-977
[4]
W. Branch-Elliman, J.E. Ripollone, W.J. O’Brien, K.M.F. Itani, M.L. Schweizer, E. Perencevich, et al.
Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: a national propensity-score-adjusted retrospective cohort study.
PLoS Med, 14 (2017), pp. e1002340
[5]
C. Liu, A. Kakis, A. Nichols, M.D. Ries, T.P. Vail, K.J. Bozic.
Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA.
Clin Orthop Relat Res, 472 (2014), pp. 227-231
[6]
E. Tornero, S. García-Ramiro, J.C. Martínez-Pastor, G. Bori, J. Bosch, L. Morata, et al.
Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty.
Antimicrob Agents Chemother, 59 (2015), pp. 831-837
[7]
A. Soriano, D. Popescu, S. García, G. Bori, J.A. Martínez, V. Balasso, et al.
Usefulness of teicoplanin for preventing methicillin-resistant Staphylococcus aureus infections in orthopedic surgery.
Eur J Clin Microbiol Infect Dis, 25 (2006), pp. 35-38
[8]
A. Capdevila, M. Navarro, G. Bori, E. Tornero, P. Camacho, J. Bosch, et al.
Incidence and risk factors for infection when teicoplanin is included for prophylaxis in patients with hip fracture.
Surgery, 17 (2016), pp. 381-384

Please cite this article as: del Toro López MD, Rodríguez-Baño J. Cómo limitar los sesgos en estudios cuasiexperimentales. Enferm Infecc Microbiol Clin. 2019;2020:45–46.

Copyright © 2019. Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.eimce.2019.05.002
No mostrar más